Sarepta Therapeutics Inc.

NASDAQ: SRPT · Real-Time Price · USD
21.82
1.52 (7.49%)
At close: Aug 15, 2025, 3:59 PM
21.76
-0.30%
After-hours: Aug 15, 2025, 07:58 PM EDT

Sarepta Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
196.89M -447.51M 159.05M 33.61M 6.46M 36.12M 45.66M -40.94M -23.94M -516.75M -109.24M -257.74M -231.48M -105.03M -121.98M -48.14M -81.41M -167.25M
Depreciation & Amortization
10.84M 9.98M 10.46M 1.84M 12.73M 12.7M 15.23M 10.93M 10.79M 11.3M 10.55M 10.7M 9.89M 10.72M 10.14M 10.49M 8.45M 8.93M
Stock-Based Compensation
37.02M 41.43M 49.68M 43.45M 50.48M 40.69M 45.83M 48.06M 47.38M 41.25M 50.51M 50.42M 102.89M 29.2M 29.78M 26.68M 28.97M 28.51M
Other Working Capital
47.03M -47.03M 79.92M 518.37M -39.32M -197.78M -35.8M -22.5M -22.25M -52M -42.27M -19.02M -4.73M -8.6M 6.55M -22.01M 16.5M 12.91M
Other Non-Cash Items
-265.2M 94.44M -2.14M -524.59M 72.65M 474.14M -36K 3.23M -101.75M 383.86M 7.18M 121.67M 6.43M 7.45M 5.62M -5.1M -99.11M 4.59M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -11.04M 18.72M -7.68M n/a n/a n/a n/a n/a 1.21M 8.68M 3.78M 2.14M
Change in Working Capital
281.78M -281.78M -124.99M 374.99M -45.38M -329.61M -150.29M -154.71M -47.03M -129.06M -51.39M 9.99M 45.45M -43.52M 45.9M -116.95M 30.17M -57.29M
Operating Cash Flow
261.34M -583.44M 92.05M -70.7M 14.94M -242.08M -54.66M -114.71M -122.23M -209.4M -92.39M -64.96M -66.81M -101.17M -29.33M -124.33M -109.15M -180.37M
Capital Expenditures
-29.56M -45.89M -38.08M -27.26M -29.17M -42.44M -19.04M -40.91M -17.91M -9.48M -7.96M -8.23M -9.08M -5.55M -2.21M -9.24M -5.89M -21.15M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 11.24M -11.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
241.39M -286.05M -162.91M -389.4M -330.83M -216.45M -573.54M -645.61M -403.04M -426.76M -427.54M -371.71M -357.83M -779.77M n/a 1K n/a -29.99M
Sales Maturities Of Investments
68.63M 40.76M 965.11M 297.84M 261.47M 477.69M 528.22M 475.81M 415.62M 448.83M 446.5M 399.57M 77.15M n/a n/a 30M 226M 210M
Other Investing Acitivies
-246.01M -2.24M n/a -10M -69.36M 251.24M -11.24M 11.38M 101.95M -94K -1.2M -507K -232K -486K -371K -495K 100.95M -2.2M
Investing Cash Flow
32.21M -291.18M 764.12M -128.82M -98.53M 218.8M -64.36M -210.57M 96.63M 12.49M 9.8M 19.12M -289.99M -785.81M -2.58M 20.27M 321.06M 156.67M
Debt Repayment
n/a -3.21M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-25.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6.33M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.2M 12.47M 48.99M 13.76M 39.92M 22.14M 1.94M 15.4M 5.86M 101.8M 10.75M 216.43M 339K 4.99M 716K 5.9M 3.53M 2.89M
Financial Cash Flow
-23.82M 12.47M 48.99M 13.76M 39.92M 22.14M 1.94M 15.4M 5.86M 101.8M 10.75M 216.43M 339K 4.99M 549.25M 5.9M 3.53M 2.89M
Net Cash Flow
269.73M -862.14M 905.15M -170.19M -43.67M -1.14M -113.5M -309.87M -19.74M -95.11M -71.85M 170.58M -356.47M -881.99M 517.35M -98.16M 215.44M -20.81M
Free Cash Flow
231.78M -629.33M 53.96M -97.96M -14.22M -284.52M -73.7M -155.62M -140.14M -218.88M -100.36M -73.19M -75.89M -106.73M -31.53M -133.57M -115.04M -201.52M